Adamax 10 mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Adamax supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF102025050

Key analytical results include:

• Assay Content: 10.34 mg
• Identification – Retention Time: 0.993
• Identification – Spectrum: 995
• Purity: 99.2 percent
• Bacterial Endotoxins: detected but below 0.01 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Adamax is a synthetic research peptide studied in controlled laboratory environments focused on cellular signalling pathways and molecular regulatory mechanisms.

The compound belongs to a category of experimental peptide-based molecules investigated for their interaction with biological signalling systems and intracellular regulatory networks.

This preparation contains 10 mg of high purity lyophilized compound supplied in a sealed research vial. The lyophilization process preserves molecular stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and verified analytical profile, Adamax has been referenced in experimental models exploring peptide-mediated regulatory signalling pathways.

Compound Overview

Adamax is a synthetic peptide compound designed for biochemical research investigating peptide-receptor interaction and cellular signalling pathways.

Peptide-based compounds are commonly studied in molecular biology due to their ability to interact with receptor systems and intracellular regulatory networks.

Within experimental research environments, such compounds are utilised to explore signalling cascades, receptor binding dynamics and molecular regulatory processes.

The defined peptide structure of Adamax allows researchers to evaluate its behaviour within controlled biochemical models focused on signalling pathways and peptide interaction systems.

Historical Background and Scientific Context

Scientific interest in synthetic peptides expanded significantly during the late twentieth century as advances in peptide synthesis and molecular biology techniques enabled researchers to design targeted experimental molecules.

Throughout the 1990s and early 2000s, peptide engineering became a widely used approach in biochemical research investigating receptor signalling systems and regulatory protein networks.

During this period researchers began developing a wide range of experimental peptides capable of interacting with specific molecular pathways.

Compounds such as Adamax represent examples of modern research peptides developed to explore peptide-receptor interactions and intracellular signalling dynamics in laboratory models.

Mechanistic Focus in Research

Within experimental laboratory settings, Adamax is studied in relation to peptide-mediated signalling pathways and molecular interaction systems.

Research investigations commonly explore the compound in experimental models examining:

• Peptide receptor interaction mechanisms
• Cellular signalling pathway dynamics
• Intracellular regulatory network modelling
• Comparative peptide interaction studies
• Molecular signalling cascade analysis
• Experimental receptor-binding research
• Peptide-mediated biochemical processes

These experimental models allow scientists to investigate molecular regulatory mechanisms that influence cellular signalling behaviour and biochemical pathway interactions.

Research Applications

In controlled research environments, Adamax may be utilised in experimental models designed to explore peptide signalling systems and intracellular regulatory pathways.

Examples of research applications include:

• Peptide signalling pathway investigation
• Receptor interaction analysis
• Molecular signalling research
• Comparative peptide compound evaluation
• Cellular regulatory pathway modelling
• Experimental biochemical signalling studies
• Controlled in vitro peptide interaction research

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 10.34 mg
Confirmed purity 99.2 percent
Retention time and spectral identity confirmation
Endotoxin detected but below 0.01 EU per mg
No detectable microbial contamination
No detectable heavy metals
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.